M&A Deal Summary |
|
|---|---|
| Date | 2025-02-05 |
| Target | BioAssay Systems |
| Sector | Life Science |
| Buyer(s) | VION Biosciences |
| Deal Type | Add-on Acquisition |
SEARCH BY
VION Biosciences is a life science platform delivering market-leading manufacturing and mission-critical chemicals and specialty reagents alongside value-added services to enable scientific discovery, clinical testing, therapeutic development, and innovative solutions across a wide platform of key applications in the biochemical and life science sectors, from research to commercialization. VION Biosciences is based in Cleveland, Ohio,
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 4 of 4 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-08-22 |
Echelon Biosciences
Salt Lake, Utah, United States Echelon Biosciences specializes in lipid cell signaling and metabolic enzyme research, offering products such as biochemical reagents, assays, and custom synthesis services. Echelon Biosciences is based in Salt Lake City, Utah. |
Buy | - |
